Search | TVST | ARVO Journals

tvst

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (4)
Journal Articles (1)

Journal

Investigative Ophthalmology & Visual Science (4)
Translational Vision Science & Technology (1)

Article Type

ARVO Annual Meeting Abstract (4)
Clinical Trials (1)

Topics

Pharmacology (1)
Translational Research (1)

Tags

adrenal corticosteroids (1)
adverse event (1)
eye (1)
glucocorticoids (1)
injections (1)
intravitreal injections (1)
mineralocorticoids (1)
rapamycin (1)
safety (1)
save trial (1)

Specify Date Range

From: To: Apply

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Clinical Trials March 2015

One-Year Outcomes of the SAVE Study: S irolimus as a Therapeutic A pproach for U VE itis

PDF

Mohamed A. Ibrahim; Yasir J. Sepah; Anthony Watters; Millena Bittencourt; Erin M. Vigil; Diana V. Do; Quan Dong Nguyen
TAGS: eye, injections, rapamycin, save trial, uveitis, visual acuity, adrenal corticosteroids, glucocorticoids, mineralocorticoids, adverse event
Trans. Vis. Sci. Tech.. 2015; 4(2):4. doi: https://doi.org/10.1167/tvst.4.2.4

ARVO Annual Meeting Abstract June 2013

Assessment of Changes in Quality of Life Among Patients in the SAVE Study - Sirolimus As Therapeutic Approach To UVEItis: A Randomized Study To Assess The Safety And Bioactivity Of Intravitreal And Subconjunctival Injections Of Sirolimus In Patients With Non-infectious Uveitis

Erin Vigil; Yasir Sepah; Owhofasa Agbedia; Anthony Watters; Mohammad sadiq; Mehreen Ansari; Millena Bittencourt; Mohamed Ibrahim; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5391. doi:

ARVO Annual Meeting Abstract June 2013

12-Month Results of the SAVE Study - Sirolimus as Therapeutic Approach to UVEitis: A Randomized Study to Assess the Safety and Bioactivity of Intravitreal and Subconjunctival Injections of Sirolimus in Patients with Non-infectious Uveitis

Quan Dong Nguyen; Mohamed Ibrahim; Anthony Watters; Yasir Sepah; Millena Bittencourt; Jithin Yohannan; Joel Naor; Naveed Shams; Diana Do

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5931. doi:

ARVO Annual Meeting Abstract March 2012

Primary Endpoint Results Of The SAVE Study - Sirolimus As Therapeutic Approach To UVEItis: A Randomized Study To Assess The Safety And Bioactivity Of Intravitreal And Subconjunctival Injections Of Sirolimus In Patients With Non-infectious Uveitis

Quan Dong Nguyen; Mohamed Ibrahim; Anthony Watters; Millena Bittencourt; Jithin Yohannan; Yasir J. Sepah; Joel Naor; Naveed K. Shams; James P. Dunn; Diana V. Do

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2251. doi:

ARVO Annual Meeting Abstract April 2011

Sirolimus as Therapeutic Approach to Uveitis: A Randomized Study to Assess the Safety and Bioactivity of Intravitreal and Subconjunctival Injections of Sirolimus in Patients with Non-Infectious Uveitis (The Save Study)

Mohamed A. Ibrahim; Anthony Watters; Zubir Rentiya; Yasir J. Sepah; Henry A. Leder; Elham Hatef; Joel Naor; Naveed K. Shams; James P. Dunn; Quan D. Nguyen

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4295. doi:

« Previous

Advertisement

Follow @ARVOtvst

TVST Home
Issues
Topics
For Authors

About
- Editorial Board

Online ISSN: 2164-2591

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept